Fundraising Fox

Neurona Therapeutics

South San Francisco, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

CN
Cory NicholasExecutive Officer, Director, Promoter
JS
James StutzExecutive Officer
AK
Arnold KriegsteinDirector
SH
Stephen HauserDirector
DG
David GoeddelDirector
PS
Peter SvennilsonDirector
TK
Tim KutzkeyDirector
RK
Ray KelleherDirector
LG
Leo GuthartDirector
BM
Brad MargusDirector
EW
Erica WhittakerDirector

Investors · 1

The Column GroupreportedSan Francisco · $30Mvia David Goeddel · board

Reported raises · per SEC filings

Form D private placements
▶$101.7MraisedApr 2025 · 46 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter SvennilsonDirector
  • Tim KutzkeyDirector
  • Brad MargusDirector
  • Cory NicholasExecutive Officer, Director, Promoter
  • James StutzExecutive Officer
  • Ray KelleherDirector
  • Erica WhittakerDirector
  • Leo GuthartDirector
Offering amount
$101.7M
Amount sold
$101.7M
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$120MraisedFeb 2024 · 35 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ray KelleherDirector
  • Erica WhitakerDirector
  • Brad MargusDirector
  • Tim KutzkeyDirector
  • Robert TjianDirector
  • Leo GuthartDirector
  • Cory NicholasExecutive Officer, Director, Promoter
  • James StutzExecutive Officer
Offering amount
$120M
Amount sold
$120M
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$72MraisedDec 2022 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Arnold KriegsteinDirector
  • Leo GuthartDirector
  • Tim KutzkeyDirector
  • Stephen HauserDirector
  • Robert TjianDirector
  • Erica WhittakerDirector
  • Cory NicholasExecutive Officer, Director
  • Brad MargusDirector
Offering amount
$91.6M
Amount sold
$72M
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedNov 2019 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Leo GuthartDirector
  • Stephen HauserDirector
  • Robert TjianDirector
  • Arnold KriegsteinDirector
  • Cory NicholasExecutive Officer, Director
  • Tim KutzkeyExecutive Officer, Director
Offering amount
$50M
Amount sold
$15M
First sale
Nov 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedFeb 2018 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Leo GuthartDirector
  • Robert TijanDirector
  • Stephen HauserDirector
  • Tim KutzkeyExecutive Officer, Director
  • Arnold R. KriegsteinDirector
Offering amount
$20M
Amount sold
$10M
First sale
Feb 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$28.7MraisedDec 2016 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Arnold KriegsteinDirector
  • Stephen HauserDirector
  • Tim KutzkeyExecutive Officer, Director
  • David GoeddelDirector
  • Leo GuthartDirector
Offering amount
$30.3M
Amount sold
$28.7M
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.